全文获取类型
收费全文 | 1237946篇 |
免费 | 101156篇 |
国内免费 | 22303篇 |
专业分类
耳鼻咽喉 | 14908篇 |
儿科学 | 36580篇 |
妇产科学 | 31392篇 |
基础医学 | 175395篇 |
口腔科学 | 31790篇 |
临床医学 | 125224篇 |
内科学 | 225957篇 |
皮肤病学 | 25139篇 |
神经病学 | 92521篇 |
特种医学 | 47599篇 |
外国民族医学 | 503篇 |
外科学 | 172493篇 |
综合类 | 66912篇 |
现状与发展 | 74篇 |
一般理论 | 411篇 |
预防医学 | 91979篇 |
眼科学 | 30442篇 |
药学 | 98775篇 |
293篇 | |
中国医学 | 17450篇 |
肿瘤学 | 75568篇 |
出版年
2021年 | 18030篇 |
2020年 | 14828篇 |
2019年 | 16372篇 |
2018年 | 20001篇 |
2017年 | 16576篇 |
2016年 | 17300篇 |
2015年 | 22540篇 |
2014年 | 29089篇 |
2013年 | 34254篇 |
2012年 | 47204篇 |
2011年 | 51871篇 |
2010年 | 31280篇 |
2009年 | 27281篇 |
2008年 | 41775篇 |
2007年 | 43431篇 |
2006年 | 44215篇 |
2005年 | 43220篇 |
2004年 | 36890篇 |
2003年 | 35157篇 |
2002年 | 32929篇 |
2001年 | 52088篇 |
2000年 | 53927篇 |
1999年 | 46821篇 |
1998年 | 15118篇 |
1997年 | 14097篇 |
1996年 | 13097篇 |
1995年 | 13183篇 |
1994年 | 11909篇 |
1993年 | 10349篇 |
1992年 | 34279篇 |
1991年 | 33173篇 |
1990年 | 32478篇 |
1989年 | 31106篇 |
1988年 | 28224篇 |
1987年 | 28193篇 |
1986年 | 26073篇 |
1985年 | 25134篇 |
1984年 | 18677篇 |
1983年 | 15656篇 |
1982年 | 9344篇 |
1979年 | 16903篇 |
1978年 | 12191篇 |
1977年 | 10281篇 |
1976年 | 9718篇 |
1975年 | 10153篇 |
1974年 | 12298篇 |
1973年 | 11827篇 |
1972年 | 10878篇 |
1971年 | 10104篇 |
1970年 | 9370篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
23.
目的 分析重症患者营养支持期间发生再喂养综合征的危险因素,为早期识别及预防再喂养综合征提供参考。方法 检索中国知网、万方数据库、中华医学期刊全文数据库、中国生物医学文献数据库、维普网、PubMed、Embase、Cochrane Library、Elsevier关于重症患者再喂养综合征危险因素的文献,检索时间为各数据库建库至2021年12月,采用RevMan5.3进行Meta分析。结果 纳入13篇文献,包括2 519例患者,其中病例组793例,对照组1 726例;Meta分析合并效应值显示年龄(WMD=4.69)、APACHEⅡ评分(WMD=2.50)、BMI(WMD=-0.94)、白蛋白水平(OR=4.61)、前白蛋白水平(WMD=-53.46)、基线血镁水平(WMD=-0.05)、基线血钾水平(WMD=0.18)、基线血磷水平(WMD=-0.07)是重症患者发生再喂养综合征的危险因素(P<0.05,P<0.01)。结论 基于现有证据,重症患者再喂养综合征的危险因素包括年龄、APACHEⅡ评分、营养状况及电解质水平,医护人员需密切关注重症患者营养支持期间能量、蛋白质及电解... 相似文献
24.
Keith B. Diamond Ivan J. Golub Asad M. Ashraf Samuel J. Swiggett Paul V. Romeo Jack Choueka 《Seminars in Arthroplasty》2022,32(1):15-22
BackgroundWhile studies have demonstrated favorable outcomes in utilization of primary total shoulder arthroplasty (TSA) for the treatment of glenohumeral osteoarthritis (OA), adverse events such as infections can still occur. Periprosthetic joint infections (PJIs) are associated with worse outcomes and patient morbidity. The purpose of this study was to: (1) compare patient demographics amongst TSA patients with and without PJIs following primary TSA; and (2) identify patient-related risk factors for PJIs following primary TSA.MethodsPatients undergoing primary TSA for the treatment of glenohumeral OA were identified using the Mariner administrative claims database by CPT code 23,472. Laterality modifiers were utilized to ensure PJIs were developing in the correct laterality as those patients undergoing primary TSA. Inclusion for the study group consisted of patients who developed PJIs within 2-years after the index procedure, whereas patients who did not develop PJIs served as the comparison cohort. Primary outcomes analyzed included patient demographics and patient-related risk factors for PJIs following primary TSA. A stepwise backwards elimination multivariate binomial logistic regression analyses was performed to determine the odds (OR) of PJIs in patients undergoing primary TSA. A P value less than .05 was considered statistically significant.ResultsThe query yielded 15,396 patients who underwent primary TSA for glenohumeral OA, of which 191 patients developed PJIs and 15,205 did not develop PJIs. The study found statistically significant differences amongst patients who did and did not develop PJIs following primary TSA with respect to age, sex, and presence of comorbid conditions. Risk factors associated with developing PJIs following primary TSA included: pathologic weight loss (OR: 2.06, P < .0001), obesity (OR: 1.56, P = .0001), male sex (OR: 1.52, P = .007), and peripheral vascular disease (OR: 1.46, P = .022).ConclusionAs the number of primary TSAs for the treatment of glenohumeral OA increase worldwide, identifying modifiable risk-factors to reduce the incidence of infection is critical. The study found various modifiable and non-modifiable risk factors associated with developing PJIs following primary TSA. This study is valuable to orthopedists in order to identify and risk-stratify patients with regard to PJI in the setting of primary TSA for OA.Level of EvidenceLevel III; Case-Control Study 相似文献
25.
Dong-Xin Hu Qi-Feng Sun Lin Xu Hong-Da Lu Fan Zhang Zhen-Miao Li Ming-Yan Zhang 《World journal of gastroenterology : WJG》2022,28(4):464-478
BACKGROUND Esophageal squamous cell carcinoma(ESCC)is one of the most prevalent malignancies that seriously threaten people’s health worldwide.DEAD-box helicase 51(DDX51)is a member of the DEAD-box(DDX)RNA helicase family,and drives or inhibits tumor progression in multiple cancer types.AIM To determine whether DDX51 affects the biological behavior of ESCC.METHODS The expression of DDX51 in ESCC tumor tissues and adjacent normal tissues was detected by Immunohistochemistry(IHC)analyses and quantitative PCR(qPCR).We knocked down DDX51 in ESCC cell lines by using a small interfering RNA(siRNA)transfection.The proliferation,apoptosis,and mobility of DDX51 siRNAtransfected cells were detected.The effect of DDX51 on the phosphoinositide 3-kinase(PI3K)/AKT pathway was investigated by western blot analysis.A mouse xenograft model was established to investigate the effects of DDX51 knockdown on ESCC tumor growth.RESULTS DDX51 exhibited high expression in ESCC tissues compared with normal tissues and represented a poor prognosis in patients with ESCC.Knockdown of DDX51 induced inhibition of ESCC cell proliferation and promoted apoptosis.Moreover,DDX51 siRNA-expressing cells also exhibited lower migration and invasion rates.Investigations into the underlying mechanisms suggested that DDX51 knock down induced inactivation of the PI3K/AKT pathway,including decreased phosphorylation levels of phosphate and tensin homolog,PI3K,AKT,and mammalian target of rapamycin.Rescue experiments demonstrated that the AKT activator insulin-like growth factor 1 could reverse the inhibitory effects of DDX51 on ESCC malignant development.Finally,we injected DDX51 siRNA-transfected TE-1 cells into an animal model,which resulted in slower tumor growth.CONCLUSION Our study suggests for the first time that DDX51 promotes cancer cell proliferation by regulating the PI3K/AKT pathway;thus,DDX51 might be a therapeutic target for ESCC. 相似文献
26.
27.
28.
A 2-year-old girl was diagnosed as Weill-Marchesani syndrome with typical systemic features of short stature, short and stubby hands and feet, language disorders and mental retardation. He developed bilateral angle closure glaucoma, ectopia lentis and suffered visual loss from the ocular features of Weill-Marchesani syndrome. The child was successfully treated by combined CO2 laser-assisted sclerectomy surgery and trabeculectomy. 相似文献
29.
30.
Guoliang Zhang & Tao Xiong 《Communications In Computational Physics》2022,32(1):126-155
We propose a high order finite difference linear scheme combined with a
high order bound preserving maximum-principle-preserving (MPP) flux limiter to
solve the incompressible flow system. For such problem with highly oscillatory structure but not strong shocks, our approach seems to be less dissipative and much less
costly than a WENO type scheme, and has high resolution due to a Hermite reconstruction. Spurious numerical oscillations can be controlled by the weak MPP flux
limiter. Numerical tests are performed for the Vlasov-Poisson system, the 2D guiding-center model and the incompressible Euler system. The comparison between the linear
and WENO type schemes, with and without the MPP flux limiter, will demonstrate the
good performance of our proposed approach. 相似文献